SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-125238
Filing Date
2019-04-29
Accepted
2019-04-29 16:18:04
Documents
9
Period of Report
2019-06-10
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d710203ddef14a.htm DEF 14A 541626
2 GRAPHIC g710203g03q26.jpg GRAPHIC 894
3 GRAPHIC g710203g11k97.jpg GRAPHIC 27440
4 GRAPHIC g710203g18q10.jpg GRAPHIC 2030
5 GRAPHIC g710203g23m81.jpg GRAPHIC 850
6 GRAPHIC g710203g39u47.jpg GRAPHIC 803
7 GRAPHIC g710203g60r81.jpg GRAPHIC 31873
8 GRAPHIC g710203g68k35.jpg GRAPHIC 861
9 GRAPHIC g710203g95n58.jpg GRAPHIC 2688
  Complete submission text file 0001193125-19-125238.txt   636734
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35703 | Film No.: 19776129
SIC: 2834 Pharmaceutical Preparations